Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| Active Surveillance and Radical Prostatectomy for Clinically Localized, Low-Risk Prostate Cancer |
|
Stakeholder organizations invited to participate:
New Evidence Active Surveillance/Radical Prostatectomy: Analysis of New Evidence Final Appraisal Documents Executive Summary - Active Surveillance and Radical Prostatectomy Final Appraisal Active Surveillance and Radical Prostatectomy Final Appraisal Draft Documents Draft Appraisal for Active Surveillance and Radical Prostatectomy Mid-Cycle Review Documents Clinical Subcommittee Call Summary Economic Subcommittee Call Summary Systematic Review: Preliminary Findings Background Materials & Key Questions Radical Prostatectomy Overview Key Questions and Model Description Active Surveillance & Radical Prostatectomy Scoping Call Summary Active Surveillance and Radical Prostatectomy Evidence Review Group
Powered by !JoomlaComment 3.26
3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved." |
|||||||||||||||||||||||||||||||||||||||||||||||||